To view this email as a web page, click here.
 
TOP STORIES
 
More Manufacturers Freeze Drug Prices: Will Positive Momentum Last?
Are recent pharma price drops just a response to political pressure or will the momentum last? Managed Healthcare Executive asked industry experts, and here's what they said.
Read more
ADVERTISEMENT
 
Formulary Drug Exclusions on the Rise: What Health Execs Should Know
Find out which drugs PBMs are excluding and why.
Read more
ADVERTISEMENT
 
How Opioid Use Disorder Meds Affect Opioid Death Rates
A first-of-its kind study examined the association between using medication to treat OUD and mortality in patients who had a nonfatal opioid overdose.
Read more
 
DIGITAL EDITION
Check out our July issue featuring:
 • Executive Compensation Changes
 • Generic Drug Cost Predictions
 • Embedded Care Managers
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.